IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS

IRON CHELATION THERAPY WITH DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN PRIMARY MYELOFIBROSIS

Deferasirox (DSX) is the principal option currently available for iron-chelation-therapy (ICT), principally in the management of myelodysplastic syndromes (MDS), while in primary myelofibrosis (PMF) the expertise is limited. We analyzed our experience in 10 PMF with transfusion-dependent anemia, tre...

Full description

Bibliographic Details
Main Authors: Elena Maria Elli, Angelo Belotti, Andrea Aroldi, Matteo Parma, Pietro Pioltelli, Enrico Maria Pogliani
Format: Article
Language:English
Published: PAGEPress Publications 2014-05-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Iron overload
Primary Myelofibrosis
Deferasirox
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/1389

Internet

http://www.mjhid.org/index.php/mjhid/article/view/1389

Similar Items